U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.658_659del (p.Val220fs) AND Uterine corpus cancer

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 21, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003128126.8

Allele description [Variation Report for NM_000059.4(BRCA2):c.658_659del (p.Val220fs)]

NM_000059.4(BRCA2):c.658_659del (p.Val220fs)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.658_659del (p.Val220fs)
Other names:
886_887delGT
HGVS:
  • NC_000013.10:g.32903605_32903606del
  • NC_000013.11:g.32329469_32329470del
  • NG_012772.3:g.18990_18991del
  • NM_000059.4:c.658_659delMANE SELECT
  • NP_000050.3:p.Val220fs
  • LRG_293:g.18990_18991del
  • NC_000013.10:g.32903605_32903606del
  • NC_000013.10:g.32903606_32903607del
  • NC_000013.10:g.32903606_32903607del
  • NC_000013.10:g.32903606_32903607delGT
  • NC_000013.11:g.32329469_32329470delGT
  • NM_000059.3:c.657_658del
  • NM_000059.3:c.658_659delGT
  • U43746.1:n.886_887delGT
  • p.V220IFS*4
  • p.V220IfsX4
  • p.Val220Ilefs*4
  • p.Val220IlefsX4
  • p.Val220fs
Nucleotide change:
886delGT
Links:
Breast Cancer Information Core (BIC) (BRCA2): 886&base_change=del GT; OMIM: 600185.0027; dbSNP: rs80359604
NCBI 1000 Genomes Browser:
rs80359604
Molecular consequence:
  • NM_000059.4:c.658_659del - frameshift variant - [Sequence Ontology: SO:0001589]
Observations:
1

Condition(s)

Name:
Uterine corpus cancer
Identifiers:
MONDO: MONDO:0006003; MedGen: C1883486

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003804356CZECANCA consortium
no assertion criteria provided
Pathogenic
(Feb 21, 2023) 		germlineclinical testing

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Slavicgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From CZECANCA consortium, SCV003804356.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Slavic1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 3, 2024